The big, the bad, and the exon 11: adjuvant imatinib for all gastro-intestinal stromal tumors or just the ugly?

Transl Gastroenterol Hepatol. 2017 Oct 13:2:81. doi: 10.21037/tgh.2017.09.10. eCollection 2017.

Authors

Roman Groisberg¹, Vivek Subbiah¹

Affiliation

¹ Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

Publication types

Editorial
Comment